Contract Manufacturing
Terumo BCT Launches C> Ecosystem Blueprint To Enable Scalable Cell And Gene Therapy Development In APAC
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. Terumo Blood and Cell Technologies (Terumo BCT) annou...
March 06, 2026 | News
Sartorius Introduces Genetically Engineered CHO Host Cell Line To Boost Biomanufacturing Productivity
New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold...
March 06, 2026 | News
Catalent And S Biomedics Partner To Advance Stem Cell Therapy For Parkinsons Disease
Catalent and S.Biomedics announced a strategic partnership to support the development and manufacturing of TED‑A9, S.Biomedics’ allogeneic pluripot...
February 23, 2026 | News
CARsgen Therapeutics Advances Commercial CAR T Cell Manufacturing With Shanghai Strategic Partnership
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that through its in...
February 17, 2026 | News
AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing
Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...
February 12, 2026 | News
Samsung Biologics PCF System Validated Against Global Carbon Accounting Standards
Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish ...
February 09, 2026 | News
Samsung Biologics Partners With Coalition for Epidemic Preparedness Innovations To Boost Outbreak Ready Vaccine Manufacturing
The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organiz...
February 05, 2026 | News
WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...
February 04, 2026 | News
Frontage Laboratories Expands Early Phase Clinical Research Capabilities Across The United States And China
Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the expansion of ...
February 03, 2026 | News
Samsung Biologics Earns EcoVadis Platinum Sustainability Rating
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis...
January 30, 2026 | News
WuXi Biologics And HanchorBio Inc. Sign Strategic Collaboration To Advance Next Generation Fusion Biologics
WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a globa...
January 27, 2026 | News
Blau Farmacêutica Achieves End To End Development Of Pembrolizumab Biosimilar In Brazil
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals w...
January 27, 2026 | News
Samsung Biologics Strengthens Long Term Growth Platform With Solid 2025 Financial Performance
Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent ...
January 22, 2026 | Company results
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
